Ally Bridge Group

Ally Bridge Group as of Sept. 30, 2025

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 22 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Soleno Therapeutics (SLNO) 22.7 $37M 553k 67.60
Replimune Group Call Option (REPL) 9.2 $15M 3.6M 4.19
Madrigal Pharmaceuticals (MDGL) 9.1 $15M 33k 458.66
Compass Pathways Sponsored Ads (CMPS) 7.6 $12M 2.2M 5.73
Atai Beckley Nv SHS (ATAI) 7.4 $12M 2.3M 5.29
Ascendis Pharma A/s - Sponsored Adr (ASND) 6.2 $10M 51k 198.81
Lenz Therapeutics (LENZ) 5.0 $8.2M 175k 46.58
Taysha Gene Therapies Com Shs (TSHA) 3.8 $6.2M 1.9M 3.27
Amylyx Pharmaceuticals (AMLX) 3.6 $5.9M 437k 13.59
Eupraxia Pharmaceuticals (EPRX) 3.3 $5.4M 915k 5.90
Praxis Precision Medicines I Com New Call Option (PRAX) 3.2 $5.3M 100k 53.00
Monopar Therapeutics Com New (MNPR) 3.2 $5.3M 65k 81.67
Arcutis Biotherapeutics (ARQT) 2.7 $4.4M 233k 18.85
Mind Medicine Mindmed Com New (MNMD) 2.6 $4.3M 361k 11.79
Tarsus Pharmaceuticals (TARS) 2.6 $4.2M 71k 59.43
Solid Biosciences Com New (SLDB) 2.1 $3.4M 549k 6.17
Promis Neurosciences Com New (PMN) 1.6 $2.6M 6.2M 0.42
Avalo Therapeutics Com New (AVTX) 1.4 $2.3M 178k 12.71
Tectonic Therapeutic (TECX) 1.3 $2.2M 139k 15.69
Aadi Bioscience (WHWK) 0.9 $1.6M 818k 1.90
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX) 0.3 $495k 69k 7.17
Atyr Pharma Com New Call Option (ATYR) 0.3 $433k 600k 0.72